Home » Articles posted by Alan Green

Author Archives: Alan Green

Alan Green discusses ECR Minerals #ECR & Eddie Stobart #ESL on StockBox Research Talks

Alan Green a research specialist presents a compelling investment case for ECR Minerals #ECR & Eddie Stobart #ESL, two very different companies on StockBox Research Talks.

ECR Minerals #ECR – Warrant Instrument Clarification

ECR Minerals plc (LON: ECR), the gold exploration and development company focused on Australia, provides a clarification as to the expiry date of certain warrants issued in July 2018.

On 11 July 2018 the Company announced a financing which included the issue of 92,857,143 new ordinary shares (the “Financing Shares”). Each Financing Share had a warrant attached to subscribe for a further new ordinary share in ECR Minerals plc at a price of 1.125p (the “Financing Warrants”).

The announcement of 11 July 2018 stated that the exercise period of the Financing Warrants was two years from the admission date of the Financing Shares and that therefore the expiry date for the Financing Warrants was 25 July 2020. However this date was provided in error and the exercise period set out in the relevant warrant documentation is three years from 30 July 2018 and therefore the expiry date for the Financing Warrants is 30 July 2021.

Accordingly, holders of the Financing Warrants have until 30 July 2021 to exercise these warrants. ECR will write to all holders of the Financing Warrant to clarify the actual expiration date of 30 July 2021.

No other warrants issued by ECR Minerals are affected by this notice.

FOR FURTHER INFORMATION, PLEASE CONTACT:

ECR Minerals plc

Tel: +44 (0)20 7929 1010

David Tang, Non-Executive Chairman

Craig Brown, Director & CEO

Email: info@ecrminerals.com

Website: www.ecrminerals.com

WH Ireland Ltd

Tel: +44 (0)161 832 2174

Nominated Adviser

Katy Mitchell/James Sinclair-Ford

SI Capital

Tel: +44 (0)1483 413500

Broker

Nick Emerson

ABOUT ECR MINERALS PLC

ECR is a mineral exploration and development company. ECR’s wholly owned Australian subsidiary Mercator Gold Australia Pty Ltd has 100% ownership of the Bailieston and Creswick gold projects in central Victoria, Australia.

Following the sale of the Avoca, Moormbool and Timor gold projects in Victoria, Australia to Fosterville South Exploration Ltd (TSX-V: FSX), ECR has the right to receive up to A$2 million in payments subject to future resource estimation or production at those projects.

ECR has earned a 25% interest in the Danglay gold project, an advanced exploration project located in a prolific gold and copper mining district in the north of the Philippines, and holds a royalty on the SLM gold project in La Rioja Province, Argentina.

Alan Green talks Boohoo #BOO, Gfinity #GFIN, Zanaga Iron Ore #ZIOC & ECR Minerals #ECR on UK Investor Mag podcast

Alan Green discussess Boohoo #BOO, Gfinity #GFIN, Zanaga Iron Ore #ZIOC & ECR Minerals #ECR with Jonathan Roy on the UK Investor Mag podcast.

LocoSoco Group #LOCO – Hand Sanitiser Supply Partnership With The Great Outdoor Gym Company.

LocoSoco Group Plc, the company that builds technology to profit from creating sustainable communities and is listed on the Direct Market segment of the Vienna MTF, is pleased to announce a new UK hand sanitiser supply partnership with The Great Outdoor Gym Company (‘TGOGC’).

LocoSoco Group Plc (LOCO) is listed on the Direct Market segment of the Vienna MTF. For quotes and trading data, link here: https://www.wienerborse.at/en/market-data/shares-others/quote-direct/?ISIN=GB00BD5BTL23&ID_NOTATION=246035708

The Great Outdoor Gym Company (TGOGC) Agreement

Great Outdoor Gym Company sponsor a further 450 NHS Forest trees ...LocoSoco have agreed a partnership with TGOGC to distribute hand sanitiser products across their network of more than 1500 gyms worldwide. TGOGC design, engineer and manufacture outdoor gym equipment for parks, schools, university campuses, hospitals, care homes, workplaces, prisons, seafronts, roof terraces, holiday camps, leisure facilities and exhibition spaces. TGOGC values for sustainability and community support are fully aligned with LocoSoco.

The key products to be supplied to TGOGC are SanitiserSafe +, a 7 day residual effect non toxic environmentally friendly powerful cleaner and HandSafe, a Covid 19 certified-in-lab hand cleaner that kills Covid and other nasties leaving a 4 hour residual effect on the hands.

TGOGC My Eco Site page link: https://myeco.site/tgo

Initial Sales

Since signing this agreement at the end of June, TGOGC have already opened up routes to market for LocoSoco, with initial sales of hand sanitiser already made to 12 UK Councils.

LocoSoco CEO James Perry commented:

“LocoSoco’s relentless efforts to build strategic partnerships and alliances are rapidly coming to fruition. Today’s agreement with TGOGC follows on from the recent Purus Air, eXpresso Plus and WeAreInverurie agreements, and demonstrates how quickly the LocoSoco network can commercialise new partnerships. As our company enters an exciting phase of growth, I look forward to providing further updates.”

The Great Outdoor Gym Company Managing Director Georgie Delaney commented:

“We need to create a more sustainable world, and fast. Our partnership with LocoSoco moves us one step further towards our goals of creating healthier, more sustainable communities, and means we can rapidly and efficiently supply our customers with innovative products that are better for the environment.”

Ends.

Enquiries:

LocoSoco Group PLC

James Perry, Chief Executive Officer

Simon Rendell, Non-Executive Chairman

+44 (0)203 538 0716

locosoco@locoso.co

 

Novus Communications Ltd

Alan Green / Jacqueline Briscoe

+44 (0)7976 431608 / +44 (0)207 448 9839

 

Keswick Global AG – Capital Market Coach

Tim Curle, Klaus Schwerdtfeger

info@keswickglobal.com / +43 (1)740 408045

 

About LocoSoco Group Plc

LocoSoco builds technology to profit from creating sustainable communities. We work with community partners to turn community assets into eco-enterprises enabling them to generate additional revenues whilst going green.

Community partners have the opportunity to engage with their local community on sustainability, whilst also earning additional revenue for themselves, their businesses and causes.

LocoSoco Group Plc listed on the Austrian Wiener Borse Direkt Market in February 2019.

Open Orphan #ORPH – Upcoming Investor Events

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models is delighted to be attending and presenting at a series of investor events from the 9th to 11th July 2020.

Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance for all of the events and will be presenting to update existing and potential investors on the Company’s business plans for 2020-2021.

No new material information will be disclosed at any event.

A full schedule of the upcoming events is as follows:

Event

Date/Time

Location

Hardman & Co Investor Forum Webinar

July 9th 2020 / 15:00 – 16:30

Virtual Event, further information and registration here: Link

Proactive Investors One2One Investor Forum

July 9th 2020 / 18:00 – 20:00

Virtual Event, further information and registration here: Link

Mello Virtual – Investing in the New World

July 11th 2020 / 9:00 – 17:00

Virtual Event, further information and registration here: Link

 

For further information please contact

Open Orphan plc

+353 (0)1 644 0007

Cathal Friel, Executive Chairman

Arden Partners plc (Nominated Adviser and Joint Broker)

+44 (0)20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer / Dan Gee-Summons

finnCap plc (Joint Broker)

+44 (0) 20 7220 500

Geoff Nash / James Thompson/ Richard Chambers

Davy (Euronext Growth Adviser and Joint Broker)

+353 (0)1 679 6363

Anthony Farrell

Camarco (Financial PR)

+44 (0)20 3757 4980

Tom Huddart / Hugo Liddy

Cadence Minerals #KDNC – Vox Markets Investor Presentation and Q&A

Cadence Minerals #KDNC CEO, Kiran Morzaria offers an overview and update of the Company’s investments and ongoing strategy.  Kiran then answers questions from the Vox Community where he discusses the Amapa Iron Ore Project, future milestones of European Metals Holding and the Company plans for the coming year.

Cadence Minerals #KDNC – Amapá Project Update

Further to the announcement made on the 16 June 2020, at this point, the commercial court of São Paulo has not made a ruling concerning DEV Mineraço S.A’s (“DEV”) petition to annul the secured creditors’ liens and charges over the Amapá Iron Ore Project (“Amapá Project”). The parties are in active discussions concerning a settlement, and we look forward to updating the market in due course.

Cadence Amapá Project stake

As mentioned in previous announcements there remains only one major precondition for Cadence to make its initial investment in the Amapá Project and release the sum currently held in escrow in a judicial trust account (“Escrow Monies”).

This precondition requires the owner of the Amapá Project (DEV), and the investors (Cadence and Indo Sino Pty Ltd) to reach a settlement agreement with the secured bank creditors. On satisfaction of the prerequisites and the release of the Escrow monies, Cadence will become a 20% shareholder in the Amapá Project via our joint venture company which will own 99.9% of DEV.

Cadence’s rights over the Amapá Project have been formalised in the Judicial Restructuring Plan of DEV and ratified by the São Paulo Bankruptcy court. Further detail concerning Cadence’s rights, potential investment and the Judicial Restructuring Plan are detailed in the announcements of the 7,8 of August and our year-end results published on the 26 June 2020. 

About the Project

The Amapá Project was owned by Anglo American plc and Cliffs Natural Resources and consists of a large-scale iron ore mine, beneficiation plant, railway and private port.  In 2012 the operation produced 6.1 Mt of iron ore concentrate and reported operating profits from their 70% ownership in the Amapá Project of US$120 million (100% – US$171 million). Before its sale in 2012, Anglo American valued its 70% stake at US$462m in its 2012 Annual Report (100% – US$600m).

As previously announced, the total historical mineral resource contains an estimated 348 Mt of ore @ 38.9% iron content (“Fe”). The ore is beneficiated at the mine to 65% Fe Pellet Feed and 62% Fe Spiral Concentrate. Based on available historic mine plans and an independent consultant review, it is expected that at full production the Amapá Project has a mine life of 14 years and at full capacity is targeting to produce up to 5.3 Mt of iron ore per annum.

– Ends –

 

For further information:

Cadence Minerals plc

+44 (0) 207 440 0647

Andrew Suckling

Kiran Morzaria

WH Ireland Limited (NOMAD & Broker)

+44 (0) 207 220 1666

James Joyce

James Sinclair-Ford

Novum Securities Limited (Joint Broker)

+44 (0) 207 399 9400

Jon Belliss

Open Orphan #ORPH – Additional Laboratory Services Contracts Signed with NOBACZ & Nearmedic International

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce that as part of opening up its hVIVO laboratory services to third parties that it has signed 3 new contracts with third parties; NoBACZ Ltd who are a spin-out company of the University of Cambridge, a new second contract with Nearmedic International Ltd and a contract to run in-vitro testing from its laboratory for a Cambridge, Massachusetts biotech.

NoBACZ Ltd is developing an environmentally friendly antimicrobial, antiviral coating that prevents common-touch surfaces from being a major source of infection transmission during and beyond the COVID-19 outbreak. The innovative, customisable antimicrobial coating has a multitude of applications across public spaces and industries. Applied as a liquid, the NoBACZ product is adhesive and water repellent and sets into a solid but flexible barrier that is robust enough to form a semi-permanent coating on a wide variety of surfaces. The product’s composition can be fine-tuned to produce a thin or thick coating to suit different surfaces and materials, with the ability to adapt the product’s life-span before it naturally degrades such that there is no need to manually remove it.  

NoBACZ Ltd is working with hVIVO, at its state-of-the-art laboratory in East London, to test its products against a range of viruses, including coronaviruses and ultimately, against SARS-CoV-2, the virus strain that causes COVID-19 disease. If successful, the long-lasting coating can be applied to high-touch surfaces in public transport, office buildings, hospitals, gyms, care-homes, and supermarkets.

hVIVO has also recently signed a contract to run in vitro testing from its laboratory for a Cambridge, Massachusetts based biotech company. In addition, hVIVO had also signed another contract with Nearmedic International Ltd, the Company’s second in recent times, to support the development of a RegG3 drug as a treatment for COVID-19 followed by the expansion of this product into several disease areas such as Cystic Fibrosis.

As announced at Open Orphan’s recent fundraise, the group is expanding its virology and laboratory testing services to third parties. This provision of third-party laboratory services is a growth area for the Group as numerous biotechnology companies and small cap pharmaceutical companies around the world do not have their own virology laboratory. hVIVO has a unique state-of-the-art virology laboratory which it needs to run its own clinical trials, however, quite often in the past it was no more than 15% to 20% utilised. Therefore, going forward it makes great business sense to build up the laboratory services to use this underutilised capacity, i.e. our existing staff resources and facilities, to build a more profitable and sustainable business going forward. These contracts are further evidence of the Open Orphan Group executing on its strategy of building out additional and sustainable revenue lines from each of its Group companies going forward and is in line with the strategy of becoming a leading pharma services provider to the viral, and respiratory diseases sector of the pharmaceutical industry.

Cathal Friel, Executive Chairman of Open Orphan, said:

“We are now continuing to sign additional new virology services contracts with third party customers and, as such, this is delivering upon one of our key commitments from when we acquired hVIVO earlier this year that, as part of our growth strategy, we were going to expand the range of our service offerings to third party pharmaceutical and biotech companies. I am excited by this area of growth for Open Orphan as we seek to maximise the value out of our fantastic facilities in East London.”

Jonathan Powell, CEO of NoBACZ said:

“We are delighted to be working with hVIVO, a world-leading virology laboratory and pioneer of viral challenge studies, in our efforts to evaluate NoBACZ’s ground-breaking coating technology and its effectiveness at contact-killing respiratory viruses. hVIVO has the requisite experience and professional commercial focus to execute our pivotal studies rapidly and efficiently, allowing us to move forward in our ambitions to provide a quick-to-market solution for protecting the public against a resurgence of COVID-19 or similar outbreaks.” 

Rupert Holms, Chairman of Nearmedic said:

“hVIVO and Open Orphan have the unique combination of skills which shall help Nearmedic to get its novel ezrin peptide technology to the global pharmaceutical markets and  help in the fight against the COVID-19 pandemic” 

For further information please contact

Open Orphan plc

+353 (0)1 644 0007

Cathal Friel, Executive Chairman

Arden Partners plc (Nominated Adviser and Joint Broker)

+44 (0)20 7614 5900

John Llewellyn-Lloyd / Benjamin Cryer / Dan Gee-Summons

finnCap plc (Joint Broker)

+44 (0) 20 7220 500

Geoff Nash / James Thompson/ Richard Chambers

Davy (Euronext Growth Adviser and Joint Broker)

+353 (0)1 679 6363

Anthony Farrell

Camarco (Financial PR)

+44 (0)20 3757 4980

Tom Huddart / Hugo Liddy

Alan Green discusses Gfinity #GFIN, ECR Minerals #ECR & On The Beach #OTB on the Vox Markets podcast

Alan Green discusses Gfinity #GFIN, ECR Minerals #ECR & On The Beach #OTB with Justin Waite on the Vox Markets podcast

Tertiary Minerals #TYM – Issue of Equity

The Company announces that Precious Metal Capital Group LLC (“PMCG”), the subscriber under the share subscription deed details of which were announced on 2 April 2020, has requested that the Company issue 38,888,889 ordinary shares (the “Shares”) to PMCG. The purchase price of the Shares (being 0.18 pence per share or an aggregate of £70,000) had been prepaid by PMCG as part of its lumpsum investment of £600,000 in the Company, announced on 2 April 2020 and made by PMCG on 7 April 2020. Shares in relation to £420,000 of that investment remain to be issued.

Application has therefore been made for the 38,888,889 ordinary shares to be admitted to trading on AIM with admission expected to take place on 8 July 2020. These ordinary shares will rank pari passu in all respects with all existing ordinary shares in the Company. 

Following admission of the Shares, the Company’s enlarged issued share capital will comprise 831,058,315 ordinary shares with voting rights. This figure of 831,058,315 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Disclosure Rules and Transparency Rules of the United Kingdom Financial Conduct Authority.

For more information please contact:

Tertiary Minerals plc:

Patrick Cheetham, Executive Chairman

+44 (0) 1625 838 679 

SP Angel Corporate Finance LLP

Nominated Adviser and Broker

Richard Morrison

+44 (0) 203 470 0470

Caroline Rowe

Peterhouse Capital Limited

Joint Broker

Lucy Williams

+ 44 (0) 207 469 0930

Duncan Vasey

About Tertiary Minerals plc

Tertiary Minerals plc (ticker symbol ‘TYM’) is an AIM-traded mineral exploration company building and developing a multi-commodity project portfolio – Industrial minerals, base and precious metals.

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.